Neil Kumar Insider Trading $EIDX Eidos Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil Kumar.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil Kumar. Neil Kumar is Chief Executive Officer in Eidos Therapeutics, Inc. ($EIDX) and CEO and President in BridgeBio Pharma, Inc. ($BBIO) and See Remarks in BridgeBio Pharma, Inc. ($BBIO).
Neil Kumar in Eidos Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Neil Kumar: Chief Executive Officer
Holdings: 24,575,501 shares
Latest Transaction: Jul 08 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Neil Kumar in Eidos Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| May 29 2019 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Buy | P | 25.93 | 1,103,848 | 28,622,779 | 23,693,148 | 22.6 M to 23.7 M (+4.89 %) |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Option Exercise | C | 0.00 | 12,832,123 | 0 | 0 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Option Exercise | C | 0.00 | 2,909,029 | 0 | 0 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Option Exercise | X | 0.00 | 332,262 | 0 | 2,909,029 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Option Exercise | X | 10.83 | 332,262 | 3,599,992 | 0 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Buy | P | 17.00 | 1,000,000 | 17,000,000 | 19,614,655 | 18.6 M to 19.6 M (+5.37 %) |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Payment of Exercise | F | 17.00 | 211,762 | 3,599,954 | 18,614,655 | 18.8 M to 18.6 M (-1.12 %) |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Buy | C | 0.00 | 18,826,417 | 0 | 18,826,417 | 0 to 18.8 M |
Page: 1